Skip to main content
· 4/27/2009

SPEAR PHARMACEUTICALS, INC. v. William Blair & Co., LLC

Citations

  • 610 F. Supp. 2d 278
  • 2009 U.S. Dist. LEXIS 37530
  • 2009 WL 1144013

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • holding that the FDA's delay in approving a generic manufacturer's ANDA did not break the chain of causation originating from the defendant's citizen petition
  • holding that the FDA’s delay in approving a generic manufacturer’s ANDA did not break the chain of causation originating from the defendant’s citizen petition
  • holding that information relating to generic Efudex® product was the sort of “core information” that should be found in a claim for trade secret misappropriation

Source: CourtListener parenthetical corpus (CC0).

Judges: Farnan

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.